AMANDA LITTLE: Open Payments
NPI 1881294544 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 34 payments from 15 companies in 2025. Trend: 2023 $178 · 2024 $171 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 6 | $115 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $94 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| PFIZER INC. | 2 | $48 |
| Boston Scientific Corporation | 2 | $46 |
| Amgen Inc. | 2 | $34 |
| Medtronic, Inc. | 1 | $33 |
| CVRx, Inc. | 1 | $31 |
Products named: LifeVest, FARXIGA, ELIQUIS, CAMZYOS, VERQUVO, WATCHMAN FLX, WAINUA, REPATHA.
Industry payments across GA — which companies pay providers there.
